SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) Shares Bought by AlphaMark Advisors LLC

AlphaMark Advisors LLC lifted its holdings in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) by 6.7% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 6,640 shares of the company’s stock after purchasing an additional 415 shares during the quarter. AlphaMark Advisors LLC owned 0.14% of SPDR S&P Pharmaceuticals ETF worth $285,000 as of its most recent filing with the SEC.

A number of other large investors also recently modified their holdings of XPH. JPMorgan Chase & Co. lifted its position in SPDR S&P Pharmaceuticals ETF by 36.2% in the third quarter. JPMorgan Chase & Co. now owns 4,443 shares of the company’s stock worth $197,000 after purchasing an additional 1,182 shares during the period. Stifel Financial Corp acquired a new stake in shares of SPDR S&P Pharmaceuticals ETF in the third quarter valued at $337,000. CX Institutional acquired a new stake in shares of SPDR S&P Pharmaceuticals ETF in the fourth quarter valued at $438,000. Rockport Wealth LLC acquired a new position in SPDR S&P Pharmaceuticals ETF during the second quarter worth about $1,813,000. Finally, First Citizens Bank & Trust Co. grew its holdings in SPDR S&P Pharmaceuticals ETF by 9.5% during the third quarter. First Citizens Bank & Trust Co. now owns 72,053 shares of the company’s stock worth $3,196,000 after acquiring an additional 6,227 shares during the period.

SPDR S&P Pharmaceuticals ETF Trading Down 0.1 %

Shares of NYSEARCA XPH opened at $45.00 on Friday. SPDR S&P Pharmaceuticals ETF has a twelve month low of $38.88 and a twelve month high of $48.76. The firm has a 50-day moving average of $44.39 and a two-hundred day moving average of $44.24. The company has a market capitalization of $218.25 million, a price-to-earnings ratio of 14.39 and a beta of 0.87.

SPDR S&P Pharmaceuticals ETF Company Profile

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.